Market Cap 116.89M
Revenue (ttm) 0.00
Net Income (ttm) -25.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 5,000
Avg Vol 16,480
Day's Range N/A - N/A
Shares Out 35.65M
Stochastic %K 20%
Beta N/A
Analysts Strong Sell
Price Target $11.00

Latest News on EPRX

Eupraxia Pharmaceuticals Announces CFO Succession

Feb 18, 2025, 7:00 AM EST - 6 weeks ago

Eupraxia Pharmaceuticals Announces CFO Succession


Eupraxia Pharmaceuticals Strengthens Senior Management Team

Oct 2, 2024, 5:01 PM EDT - 6 months ago

Eupraxia Pharmaceuticals Strengthens Senior Management Team


Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

Apr 5, 2024, 7:00 AM EDT - 1 year ago

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today